PFE
Pfizer Inc.$24.08-1.19% 1D· price as of Jun 30, 8:32 PM-0.66% over 1Y
Compare:PFE
Mkt Cap
$137.2B
P/E
18.4×
Fwd P/E
8.5×
PEG
2.84
P/B
1.5×
P/S
2.2×
EV/EBITDA
7.4×
Beta
0.29
Div Yield
7.1%
Payout
131.3%
ROE
8.3%
Net Margin
11.8%
Short % Flt
2.8%
Inst. Own
69.4%
52-wk low $23.11$24.0852-wk high $28.75
+4.2% above low-16.2% from high
Seasonality — avg monthly return
Strongest Nov 5.5% · weakest Jan -4.5%Jan
-4.5
Feb
-3.9
Mar
+3.5
Apr
-3.2
May
+2.0
Jun
-1.6
Jul
+1.8
Aug
-0.7
Sep
-2.7
Oct
-1.1
Nov
+5.5
Dec
+0.9
Average month-over-month return per calendar month over the available history (~5 yrs); hover for the share of positive months. Past seasonality isn't predictive.
Ask AI about Pfizer Inc.
Gemini · web searchSearches the live web for current news & events plus this company's financials — and you can keep asking follow-up questions.
PFE — recent news
Loading headlines…
Quality scorecard
vs Pharmaceuticals · 7 peers · percentile rank
31 / 100
Below average
ROIC11.6%
17
ROE9.0%
17
Gross margin74.3%
67
Operating margin27.8%
33
FCF yield6.6%
50
Net debt / EBITDA3.7×
0
Percentile vs 7 Pharmaceuticals peers — higher = better (leverage inverted: less debt ranks higher). The faint tick is the peer median; the score is the average percentile. Annual fundamentals.